Health Minister Mike Nesbitt announced that pembrolizumab (Keytruda), an injectable immunotherapy cancer drug, is already in use at three of Northern Ireland's five health trusts, with plans for broader availability, following its rollout in England and Wales, aiming to enhance treatment efficiency and patient care. #CancerTreatment #Immunotherapy #HealthcareTechnology #GB #NI #ENG #WLS

